Keiko Tsuganezawa

Rational Evolution of a Novel Type of Potent and Selective Proviral Integration Site in Moloney Murine Leukemia Virus Kinase 1 (PIM1) Inhibitor from a Screening-Hit Compound

Hirofumi Nakano, Nae Saito, L.J. Parker et al. · Journal of Medicinal Chemistry · 2012 · 77 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Photo‐Cross‐Linked Small‐Molecule Microarrays as Chemical Genomic Tools for Dissecting Protein–Ligand Interactions

Naoki Kanoh, Aya Asami, Makoto Kawatani et al. · Chemistry - An Asian Journal · 2006 · 64 citations

Pharmacy, Chemical Biology, Molecular Biology +16

Flow Cytometric Diagnosis of the Cell Lineage and Developmental Stage of Acute Lymphoblastic Leukemia by Novel Monoclonal Antibodies Specific to Human Pre–B-Cell Receptor

Keiko Tsuganezawa, Nobutaka Kiyokawa, Yoshinobu Matsuo et al. · Blood · 1998 · 43 citations

Medicine, Cell Biology, Oncology +17

A Novel Pim-1 Kinase Inhibitor Targeting Residues That Bind the Substrate Peptide

Keiko Tsuganezawa, Hisami Watanabe, L.J. Parker et al. · Journal of Molecular Biology · 2012 · 30 citations

Pharmacy, Biochemistry, Medicinal Chemistry +10

Phenothiazine and carbazole-related compounds inhibit mitotic kinesin Eg5 and trigger apoptosis in transformed culture cells

Hiromi Okumura, Junko Nakazawa, Keiko Tsuganezawa et al. · Toxicology Letters · 2006 · 22 citations

Life Sciences, Cell Biology, Molecular Biology +15